Metals/metalloids
|
|
Lead |
Complications in the nervous system and red blood cells |
[27] |
|
Reduction in cognitive development and intellectual performance |
[28] |
|
Death among children |
[29] |
|
Cadmium |
Renal tubular dysfunction, associated with high risk of lung and breast cancer |
[30] |
|
Osteomalacia and osteoporosis |
|
|
Arsenic |
Associated with dermal, respiratory, nervous, mutagenic, and carcinogenic effects |
[31] |
|
Nickel |
Associated with dermatotoxicity, lower body weight, and fetotoxicity among pregnant women |
[32] |
|
Mercury |
Linked to cardiovascular, reproductive, and developmental toxicity, neurotoxicity, nephrotoxicity, immunotoxicity, and carcinogenicity |
[33] |
|
Mycotoxins
|
|
Aflatoxin |
Immunodeficiency |
[34] |
|
Aflatoxicosis |
[35] |
|
Primary hepatocellular carcinoma |
[36] |
|
Liver cirrhosis |
[37] |
|
Ochratoxin |
Nephropathy |
[38] |
|
Deoxynivalenol |
Impaired intestinal integrity |
[39] |
|
Impaired gut-associated immune system |
|
|
Zearalenone |
Hyperestrogenism and reproductive dysfunction |
[40] |
|
Fumonisins |
Esophageal cancer and birth defects |
[41] |
|
Antimicrobials
|
|
Tetracyclines |
Impaired intestinal flora |
[42] |
|
Quinolones |
Drug-resistant pathogens |
[43] |
|
Macrolides |
Hypersensitivity and anaphylactic shock |
[44] |
|
Sulfonamides |
Kidney damage and nephropathy |
[45] |
|
Polycyclic aromatic hydrocarbons (PAHs)
|
|
Benzo[a]pyrene |
Mutagenicity and carcinogenicity |
[46] |
|
DNA damage and oxidative stress |
[47] |
|
Impaired male fertility |
[48] |
|
Respiratory diseases |
[49] |
|
Cognitive dysfunction among children |
[50] |
|
Pesticides
|
|
Chlorpyrifos |
Neurological symptoms |
[51] |
|
DDTs |
Neurological symptoms |
[52] |
|
Endocrine disruption |
[53] |
|
DDT and other OCPs |
Infertility and fetal malformation |
[54] |
|
Dioxins and polychlorinated biphenyls
|
|
Dioxins and PCBs |
Language delay |
[55] |
|
Disturbances in mental and motor development |
[56] |
|
PCBs |
Neurological disorders |
[57] |